Dr. Jun Tian is WuXi Biologics’ Vice President and Head of Process and Analytical Development for the facilities located in Wuxi, China. His group focuses on late phase and commercial process development and optimization, process characterization, PPQ campaign support and BLA enabling activities.

Prior to this role, Jun has accumulated extensive experience in the biopharmaceutical industry from his time with Takeda (previously Shire), Bristol-Myers Squibb, and Life Technologies, leading a variety of early to late-stage process development activities as well as pilot plant operations.

Dr. Tian holds a Ph.D. degree in Chemical and Biological Engineering from the State University of New York at Buffalo.